Staphylococcal pore-forming toxin (PFT)

Staphylococcal pore-forming toxins (PFTs) are a diverse group of virulence factors secreted by Staphylococcus aureus that play a critical role in the pathogenesis of invasive infections [1, 3]. These toxins, which include alpha-hemolysin (Hla), bi-component leukocidins (such as Panton-Valentine Leukocidin), and phenol-soluble modulins, function by inserting into host cell membranes to form unregulated pores [4, 5]. This process leads to osmotic lysis of key immune cells, such as neutrophils and macrophages, as well as damage to epithelial and endothelial barriers, thereby facilitating bacterial spread and immune evasion [2, 12]. In addition to direct cytolysis, sub-lytic concentrations of these toxins can trigger pro-inflammatory signaling pathways, contributing to tissue damage and systemic inflammation [3, 4]. Because of their central role in disease severity and the rising challenge of antibiotic resistance, PFTs have become major targets for anti-virulence therapies, including monoclonal antibodies, vaccines, and small-molecule inhibitors that block toxin-receptor interactions or pore assembly [6, 10, 11].

Other names

Staphylococcal cytotoxinsHemolysinsLeukocidinsAlpha-hemolysin (Hla)Panton-Valentine Leukocidin (PVL)Gamma-hemolysin (Hlg)Leukocidin ED (LukED)Leukocidin AB (LukAB)Phenol-soluble modulins (PSMs)

Neutralization of toxin monomers by monoclonal antibodies [10], inhibition of toxin binding to host cell receptors such as ADAM10, CCR5, and C5aR1 [3, 4], sequestration of toxins using liposomal decoys [6], and induction of protective immunity via toxoid-based vaccines [2, 10].